Zeronil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs.

Држава: Ирска

Језик: Енглески

Извор: HPRA (Health Products Regulatory Authority)

Активни састојак:

Fipronil; (S)-methoprene

Доступно од:

Chanelle Pharmaceuticals Manufacturing Limited

АТЦ код:

QP53AX65

INN (Међународно име):

Fipronil; (S)-methoprene

Дозирање:

402, 361.8 mg/pipette

Фармацеутски облик:

Spot-on solution

Тип рецептора:

POM: Prescription Only Medicine as defined in relevant national legislation

Терапеутска група:

Dogs

Терапеутска област:

fipronil, combinations

Терапеутске индикације:

Ectoparasiticide

Статус ауторизације:

Authorised

Датум одобрења:

2018-04-20

Карактеристике производа

Health Products Regulatory Authority
06 November 2020
CRN009YGJ
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Zeronil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 4.02 ml contains:
ACTIVE SUBSTANCES:
Fipronil 402.00 mg
(S)-methoprene 361.80 mg
EXCIPIENTS:
Butylhydroxyanisole (E320) 0.80 mg
Butylhydroxytoluene (E321) 0.40 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear amber solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
- To be used against infestations with fleas, alone or in association
with ticks and/or biting lice.
- Treatment of flea infestations (_Ctenocephalides _spp.).
Insecticidal efficacy against new infestations with adult fleas
persist for 8
weeks. Prevention of the multiplication of fleas by inhibiting the
development of eggs (ovicidal activity) and larvae and pupae
(larvicidal activity) originating from eggs laid by adult fleas for
eight weeks after application.
- Treatment of tick infestations (_Ixodes ricinus_, _Dermacentor
variabilis_, _Dermacentor reticulatus_, _Rhipicephalus sanguineus_).
The
product has a persistent acaricidal efficacy for up to 4 weeks against
ticks.
- Treatment of infestations with biting lice (_Trichodectes canis_).
The product can be used as part of a treatment strategy for the
control of Flea Allergy Dermatitis (FAD).
4.3 CONTRAINDICATIONS
In the absence of available data, the product should not be used on
puppies less than 8 weeks old and/or weighing less than 2
kg.
Do not use on sick (e.g. systemic diseases, fever) or convalescent
animals.
Do not use in rabbits, as adverse reactions with even mortality could
occur.
In absence of studies, the use of the product is not recommended in
non-target species.
This product is specifically developed for dogs. Do not use in cats
and ferrets, as this could lead to overdosing.
4.4 SPECIAL WARNINGS FOR